Current pharmacotherapies of alcoholism: a U.S. perspective.
D000077443:Acamprosate; D000427:Alcohol Deterrents / Q000627:therapeutic use*; D000437:Alcoholism / Q000188:drug therapy*; D000927:Anticonvulsants / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006801:Humans; D009271:Naltrexone / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D017470:Receptors, Glutamate / Q000187:drug effects / Q000502:physiology; D012702:Serotonin Antagonists / Q000627:therapeutic use; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D013654:Taurine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D014481:United States
D000077443:Acamprosate; D000427:Alcohol Deterrents; D000927:Anticonvulsants; D009271:Naltrexone; D009292:Narcotic Antagonists; D017470:Receptors, Glutamate; D012702:Serotonin Antagonists; D017366:Serotonin Receptor Agonists; D017367:Selective Serotonin Reuptake Inhibitors; D013654:Taurine